We have shown that combined inhibition of OGT and CDK9 is toxic to prostate cancer cells (Itkonen et al. 2020), and here we used a multiomics approach to explain the mechanistic basis for the combinatorial effects. This evidence concerns the gene CDK9 and prostate cancer.